Summary
- Current Price
- As of today, ACAD price is $29.21, up +2.67% on
- Current Price All-Time High
- ACAD price is currently -50.26% below its historical high of $58.72 set on
- Market Cap
- ACAD current market cap is $5B, up +21.58% over the past 365 days
- PE Ratio
- ACAD current PE ratio is 13.16
- Revenue
- ACAD current annual revenue is $1.07B, up +11.87% year-over-year
- Next Earnings
- The next earnings release for ACAD is on
Profile
| Metric | Value |
|---|---|
| Full Name | ACADIA Pharmaceuticals Inc. |
| Ticker | NASDAQ: ACAD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | acadia.com |
| Employees | 653 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $29.21 | |
| Price, 1D Change | +2.67% | |
| $5B | ||
| - | ||
| 13.16 | ||
| 0.92 | ||
| $1.07B | ||
| Revenue, 1Y Change | +11.87% | |
| $2.30 | ||
| EPS, 1Y Change | +69.05% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $2.30 | ||
| EPS Estimate | $0.58 | N/A |
| EPS Est. Change | -74.72% | N/A |
| $1.07B | ||
| Revenue Estimate | $1.27B | N/A |
| Revenue Est. Change | +18.27% | N/A |
| Current Price | $29.21 | |
| Price Target | $36.00 | - |
| Price Tgt. Change | +23.25% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.74 | $1.36 | +84.77% | |
| $0.81 | $2.30 | +185.11% | |
| $0.58 | N/A | -74.72% | |
| $0.89 | N/A | -61.32% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $969.41M | $957.80M | -1.20% | |
| $1.08B | $1.07B | -0.86% | |
| $1.27B | N/A | +18.27% | |
| $1.43B | N/A | +33.48% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $29.21 | |
| $23.81 | ||
| $24.30 | ||
| $23.40 | ||
| $24.94 | ||
| $1.03 | ||
| 0.92 | ||
| $0.98 | ||
| 73.21 | ||
| 45.68% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $1.07B | ||
| $2.30 | ||
| $982.51M | ||
| 91.69% | ||
| $104.81M | ||
| 9.78% | ||
| $391.00M | ||
| 36.49% | ||
| $116.57M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.03 | ||
| 3.83 | ||
| 3.71 | ||
| - | ||
| 4 | ||
| 8.80 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 13.16 | ||
| 4.39 | ||
| 3.83 | ||
| 41.87 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $1.23B | ||
| $819.69M | ||
| $1.56B | ||
| $1.06B | ||
| $336.81M | ||
| $277.11M | ||
| $40.55M | ||
| $11.63M | ||
| $10.90M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $680.51M | ||
| $877.70M | ||
| $99.89M | ||
| $0.00 | ||
| $11.76M | ||
| $0.00 | ||
| -$252.10M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $109.84M | ||
| -$302.56M | ||
| $49.88M | ||
| $103.53M | ||
| $6.31M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| RBC Capital | → | |
| Oppenheimer | → | |
| Citizens | → | |
| Stifel | → | |
| BMO Capital | → | |
| RBC Capital | → | |
| B of A Securities | → | |
| Citigroup | → | |
| Canaccord Genuity | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
No data
Screeners with ACAD
FAQ
- What is the ticker symbol for ACADIA Pharmaceuticals Inc.?
- The ticker symbol for ACADIA Pharmaceuticals Inc. is NASDAQ:ACAD
- Does ACADIA Pharmaceuticals Inc. pay dividends?
- No, ACADIA Pharmaceuticals Inc. does not pay dividends
- What sector is ACADIA Pharmaceuticals Inc. in?
- ACADIA Pharmaceuticals Inc. is in the Healthcare sector
- What industry is ACADIA Pharmaceuticals Inc. in?
- ACADIA Pharmaceuticals Inc. is in the Biotechnology industry
- What country is ACADIA Pharmaceuticals Inc. based in?
- ACADIA Pharmaceuticals Inc. is headquartered in United States
- When did ACADIA Pharmaceuticals Inc. go public?
- ACADIA Pharmaceuticals Inc. initial public offering (IPO) was on May 27, 2004
- Is ACADIA Pharmaceuticals Inc. in the S&P 500?
- No, ACADIA Pharmaceuticals Inc. is not included in the S&P 500 index
- Is ACADIA Pharmaceuticals Inc. in the NASDAQ 100?
- No, ACADIA Pharmaceuticals Inc. is not included in the NASDAQ 100 index
- Is ACADIA Pharmaceuticals Inc. in the Dow Jones?
- No, ACADIA Pharmaceuticals Inc. is not included in the Dow Jones index
- When was ACADIA Pharmaceuticals Inc. last earnings report?
- ACADIA Pharmaceuticals Inc.'s most recent earnings report was on August 4, 2026
- When does ACADIA Pharmaceuticals Inc. report earnings?
- The next expected earnings date for ACADIA Pharmaceuticals Inc. is November 4, 2026
Data Sources & References
- ACAD Official Website www.acadia.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1070494/000119312526071674/0001193125-26-071674-index.htm
- ACAD Profile on Yahoo Finance finance.yahoo.com/quote/ACAD
- ACAD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/acad